Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Huang, J.
Right arrow Articles by Taylor, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, J.
Right arrow Articles by Taylor, P. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 11, 2019-2026, November 2000
© 2000 Oxford University Press

Carcinogenesis

High frequency allelic loss on chromosome 17p13.3–p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China

Jing Huang1,*, Nan Hu2,*, Alisa M. Goldstein2, Michael R. Emmert-Buck1, Ze-Zhong Tang2, Mark J. Roth2, Quan-Hong Wang2, Sanford M. Dawsey2, Xiao-You Han2, Ti Ding2, Guang Li2, Carol Giffen3 and Philip R. Taylor1,4

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing 100021, People's Republic of China,
1 National Cancer Institute, NIH, 6006 Executive Boulevard, Room 321, Bethesda, MD 20892-7058, USA,
2 Shanxi Cancer Hospital, Taiyuan, Shanxi 030013, People's Republic of China, and
3 Information Management Service Inc., Silver Spring, MD 20904, USA

Allelic loss on chromosome 17p has been reported frequently in esophageal squamous cell carcinoma (ESCC) and generally encompasses the p53 locus at 17p13.1. However, a good correlation between allelic loss on 17p and mutation of p53 has not been found. This suggests the possibility that unknown tumor suppressor genes near p53 may be involved in the development of ESCC. To evaluate this possibility, we analyzed 30 microsatellite markers covering the entire short arm of chromosome 17 in 56 ESCC patients from a high risk population in northern China, including 34 with a family history of upper gastrointestinal (UGI) cancer and 22 without a family history of any cancer. Cancer lifestyle risk factors and clinical/pathological characteristics were also collected. We found frequent allelic loss (>=65%) at 28 of the 30 markers evaluated in these ESCC patients. The highest frequencies of allelic loss (>=80%) were found in three smaller regions: deletion region I located at 17p13.3–p13.2 (between D17S849 and D17S1828); deletion region II located at 17p13.2–p13.1 (between D13S938 and TP53); deletion region III located at 17p13.1–p12 (between D17S804 and D17S799). A number of genes have already been identified in these deleted regions, including: OVCA1, OVCA2 and HIC-1 in deletion region I; p53 in deletion region II; ZNF18, ZNF29, ALDH3 and ALDH10 in deletion region III. These results will help us direct future testing of candidate genes and narrow the search region for major new tumor suppressor genes that may play a role in the pathogenesis of ESCC.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
L. R. Dearth, H. Qian, T. Wang, T. E. Baroni, J. Zeng, S. W. Chen, S. Y. Yi, and R. K. Brachmann
Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers
Carcinogenesis, February 1, 2007; 28(2): 289 - 298.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
S. Quevillon-Cheruel, N. Leulliot, M. Graille, N. Hervouet, F. Coste, H. Benedetti, C. Zelwer, J. Janin, and H. Van Tilbeurgh
Crystal structure of yeast YHR049W/FSH1, a member of the serine hydrolase family
Protein Sci., May 1, 2005; 14(5): 1350 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
S. M. Baxter, J. S. Rosenblum, S. Knutson, M. R. Nelson, J. S. Montimurro, J. A. Di Gennaro, J. A. Speir, J. J. Burbaum, and J. S. Fetrow
Synergistic Computational and Experimental Proteomics Approaches for More Accurate Detection of Active Serine Hydrolases in Yeast
Mol. Cell. Proteomics, March 1, 2004; 3(3): 209 - 225.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. Hu, A. M. Goldstein, P. S. Albert, C. Giffen, Z.-Z. Tang, T. Ding, P. R. Taylor, and M. R. Emmert-Buck
Evidence for a Familial Esophageal Cancer Susceptibility Gene on Chromosome 13
Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1112 - 1115.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Su, N. Hu, J. Shih, Y. Hu, Q.-H. Wang, E. Y. Chuang, M. J. Roth, C. Wang, A. M. Goldstein, T. Ding, et al.
Gene Expression Analysis of Esophageal Squamous Cell Carcinoma Reveals Consistent Molecular Profiles Related to a Family History of Upper Gastrointestinal Cancer
Cancer Res., July 15, 2003; 63(14): 3872 - 3876.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Hu, G. Li, W.-J. Li, C. Wang, A. M. Goldstein, Z.-Z. Tang, M. J. Roth, S. M. Dawsey, J. Huang, Q.-H. Wang, et al.
Infrequent Mutation in the BRCA2 Gene in Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., April 1, 2002; 8(4): 1121 - 1126.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.